(732) 390-7750
Contact Us
Payments
Make A Referral
Start typing & press "Enter" or "ESC" to close
Appointments
Locations
Providers
For Patients
Patient Care Information
Medical Oncology
Radiation Oncology
The Science of Treatment
Deep Inspiration Breath Hold (DIBH)
Leading-Edge HDR & LDR Brachytherapy
SpaceOAR Hydrogel
Intensity Modulated Radiation Therapy (IMRT)
Accelerated Partial Breast Irradiation (APBI)
Prone Breast Radiation Therapy
Prostate Seed Implantation
Proton Therapy
Skin Cancer Treatment
Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery
TomoTherapy
Breast Care
Hematology
Palliative & Supportive Care
Social Work
Infusion
Pharmacy
Diagnoses
Patient Portals & Useful Links
CareSpace Patient Portal
Payment Portal
Research & Trials
Clinical Trials
Medical Research News
FAQ & Resources
Before Your First Visit
New Patients
Upcoming Programs & Events
Astera Past Programs
COVID-19
Billing & Insurance
Financial Advocacy
FAQ
Online Resources
Patient Assistance Resources
Dignicap
Trials
About
News
About Us
Our Physicians
Our Care Team
Newsletter
Patient Navigators
Awards/Recognition
Careers
CONTACT-02: A Phase 3, Randomized, Open-Label, Controlled Study of Cabozantinib (XL184) in Combination With Atezolizumab vs Second Novel Hormonal Therapy (NHT) in Subjects With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Go To Trial Homepage
